Journal article
Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma
Molecular cancer, Vol.14(1), pp.10-14
01/27/2015
DOI: 10.1186/s12943-014-0274-0
PMCID: PMC4320626
PMID: 25622857
Abstract
Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the third leading cause of cancer-related death in human. Alcohol is a known risk factor for HCC. However it is still unclear whether and how alcohol enhances the progression and metastasis of existing HCC.
We first retrospectively investigated 52 HCC patients (24 alcohol-drinkers and 28 non-drinkers), and found a positive correlation between alcohol consumption and advanced Tumor-Node-Metastasis (TNM) stages, higher vessel invasion and poorer prognosis. In vitro and in vivo experiments further indicated that alcohol promoted the progression and migration/invasion of HCC. Specifically, in a 3-D tumor/endothelial co-culture system, we found that alcohol enhanced the migration/invasion of HepG2 cells and increased tumor angiogenesis. Consistently, higher expression of VEGF, MCP-1 and NF-κB was observed in HCC tissues of alcohol-drinkers. Alcohol induced the accumulation of intracellular reactive oxygen species (ROS) and the activation of NF-κB signaling in HepG2 cells. Conversely, blockage of alcohol-mediated ROS accumulation and NF-κB signaling inhibited alcohol-induced expression of VEGF and MCP-1, the tumor growth, angiogenesis and metastasis.
This study suggested that chronic moderate alcohol consumption may promote the progression and metastasis of HCC; the oncogenic effect may be at least partially mediated by the ROS accumulation and NF-ĸB-dependent VEGF and MCP-1 up-regulation.
Details
- Title: Subtitle
- Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma
- Creators
- Fei Wang - Anhui Medical UniversityJin-Lian Yang - Anhui Medical UniversityKe-ke Yu - Anhui Medical UniversityMei Xu - Anhui Medical UniversityYou-zhi Xu - Anhui Medical UniversityLi Chen - Anhui Medical UniversityYan-min Lu - Anhui Medical UniversityHao-shu Fang - Anhui Medical UniversityXin-yi Wang - Anhui Medical UniversityZhong-qian Hu - Anhui Medical UniversityFei-fei Li - Anhui Medical UniversityLixin Kan - Anhui Medical UniversityJia Luo - University of KentuckySi-Ying Wang - Anhui Medical University
- Resource Type
- Journal article
- Publication Details
- Molecular cancer, Vol.14(1), pp.10-14
- DOI
- 10.1186/s12943-014-0274-0
- PMID
- 25622857
- PMCID
- PMC4320626
- NLM abbreviation
- Mol Cancer
- ISSN
- 1476-4598
- eISSN
- 1476-4598
- Grant note
- AA015407 / NIAAA NIH HHS AA017226 / NIAAA NIH HHS R01 AA015407 / NIAAA NIH HHS R01 AA017226 / NIAAA NIH HHS
- Language
- English
- Date published
- 01/27/2015
- Academic Unit
- Pathology
- Record Identifier
- 9984201251702771
Metrics
17 Record Views